In vitro evaluation of Poly(D,L-lactide-co-glycolide) polymer-based implants containing the α-melanocyte stimulating hormone analog, Melanotan-I

Journal of Controlled Release

Volumn 45, Issue 1, 1997, Pages 49-55

  Bhardwaj, Renu ^a   Blanchard, James ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Additives; Controlled release; Implants; Melanotan I; Poly(D,L lactide co glycolide); Radiation dose

Indexed keywords

INTERMEDIN DERIVATIVE; MELATONAN I; POLYGLACTIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG IMPLANT; DRUG RELEASE; GAMMA RADIATION; PRIORITY JOURNAL; VISCOSITY;

EID: 0031023406     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01544-1     Document Type: Article

References (21)

1. 7]α-melanocyte stimulating hormone: A highly potent α-melanotropin with ultralong biological activity, Proc. Natl. Acad. Sci. USA 77 (1980) 5754-5758.
2. R.D. Griego and N. Levine, Subcutaneous administration of a potent synthetic melanotropin influences human skin darkening without sunlight exposure, J. Invest. Dermatol. 98 (1992) 645.
3. N. Levine, S.N. Sheftel, T. Eytan, R.T. Dorr, M.E. Hadley, J.C. Weinrach, G.A. Ertl, K. Toth and V.J. Hruby, Induction of skin tanning by the subcutaneous administration of a potent synthetic melanotropin, J. Am. Med. Assoc. 266 (1991) 2730-2736.
4. C.G. Pitt, The controlled parenteral delivery of polypeptides and proteins, Int. J. Pharm. 59 (1990) 173-196.
5. D.A. Wood, Biodegradable drug delivery, Int. J. Pharm. 7 (1980) 1-18.
6. B.J.A. Furr and F.G. Hutchinson, A biodegradable delivery system for peptides: preclinical experience with gonadotrophin-releasing hormone agonist Zoladex®, J. Control. Rel. 21 (1991) 117-128.
7. L.M. Sanders, B.A. Kell, G.I. McRae and G.W. Whitehead, Prolonged controlled-release of Nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants influence of composition and molecular weight of polymer, J. Pharm. Sci. 75 (1986) 356-360.
8. E.A. Schmitt, D.R. Flanagan and R.R. Linhardt, Degradation and release properties of pellets fabricated from three commercial Poly(D,L-Lactide-co-glycolide) biodegradable polymers, J. Pharm. Sci. 82 (1993) 326-329.
9. L.M. Sanders, J.S. Kent, G.I. McRae, B.H. Vickery, T.R. Tice and D.H. Lewis, Controlled release of luteinizing hormone-releasing analog from the poly(D,L-lactide-co-glycolide) microspheres, J. Pharm. Sci. 73 (1994) 1294-1300.
10. 7]α-MSH analog (Melanotan-I) in biological matrices, J. Chromatogr. 620 (1995) 235-242.
11. A.M.L. Castrucci, M.E. Hadley and V.J. Hruby, Melanotropin bioassay: in-vitro and in-vivo comparisons, Gen. Biochem. Physiol. [B] 78 (1984) 519-524.
12. H. Fukuzaki, M. Yoshida, M. Asano, M. Kumakura, T. Mashimo, H. Yuasa, K. Imai and H. Yamanaka, In vivo characteristic of high molecular weight copoly(L-lactide/ glycolide) with S-type degradation pattern for application of drug delivery systems, Biomaterials 12 (1991) 433-437.
13. A.M. Reed and D.K. Gilding, Biodegradable polymers for use in surgery-poly(glycolic) poly(lactic acid) homo- and copolymers: 2. In vitro degradation, Polymer 22 (1981) 494-498.
14. I. Grizzi, H. Garreau, S. Li and M. Vert, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials 16 (1995) 305-311.
15. M.Vert, S. Li and H. Garreau, Recent advances in the field of lactic acid/glycolic acid based therapeutic systems, Macromol. Symp. 98 (1995) 633-642.
16. J. Helder, P.J. Dijkstra and J. Feijen, In vitro degradation of glycine/DL-lactide acid copolymers, J. Biomed. Mater. Res. 24 (1990) 1005-1020.
17. R. Bodmier and H. Chen, Evaluation of biodegradable poly(lactide) pellets prepared by direct compression, J. Pharm. Sci. 78 (1989) 819-822.
18. A.C. Hausberger, R.A. Kinley and P.P Deluca, Gamma radiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-co-glycolide) microparticles, Pharm. Res. 12 (1995) 851-856.
19. D.K. Gilding and A.M. Reed, Biodegradable polymers for use in surgery-poly(glycolic) Poly(lactic acid) homo- and copolymers: 2. In vitro degradation. Polymer 20 (1979) 1459-1464.
20. A. Merkli, J. Heller, C. Tabatabay and R. Gurny, Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery -validation and radiation effects. Pharm. Res. 11 (1994) 1485-1491.
21. Sterilization and sterility assurance of compendial articles, USP 23/NF 18, United States Pharmacopeial Convention, Inc., Rockville, MD, 1995, pp. 1976-1980.